 |
Winnipeg Carcinoid Neuroendocrine Conference
|
|
Event Overview
|
Carcinoid Neuroendocrine cancers are relatively rare malignancies distinguished by small,
slow growing tumours which affect the neuro-endocrine system. These tumours typically originate in
the gastro-intestinal tract, but sometimes arise in the lungs or other organs.
A variety of excellent treatment options are available, most of which target specific peptide
receptors on the tumour cells. Among the best known treatments are Octreotide, Lanreotide and similar hormonal
treatments, which provide symptomatic relief and have anti-proliferative benefits. Other newer
therapies use these drugs in combination with radioisotopes, as a targeted radiation treatment.
On Saturday 9 May 2009, the
Carcinoid Neuroendocrine Tumour Society Canada held a conference at Fort Garry Hotel in Winnipeg, Canada.
The theme of the event was "Neuroendocrine Malignancies" and the focus was on emerging modes of treatment.
It was a cold and snowy day, but some 70 persons attended, mostly patients and family caregivers.
They were treated to some extraordinary presentations by a panel of Canadian and International physicians.
Targeted radiation treatments and their related issues for Canadians were the subject of a special
breakfast meeting session.
At the end of the day, there was a spirited audience question and answer session, with many physicians (even those
seated within the audience) tackling the questions posed. For those questions which could not be answered
during the Q&A session, the physicians
replied in writing after the conference.
These recordings were made to share the information more widely.
|
|
Recordings
Following are recordings of the various presentations.
|
|
- Introduction and Overview of NETs
Presenter(s): Maureen Coleman, President, CNETS Canada; Jim Kormos, Vice President, CNETS Canada;
Dr Ralph Wong, Medical Oncologist, St Boniface Hospital, Winnipeg, Manitoba
Duration: 21 minutes
View:
broadband video
|
standard video
|
audio (MP3)
-
Diagnosis of Gastroenteropancreatic Neuroendocrine Tumours
Presenter(s):
Prof Sylvia Asa, Chief of Pathology University Health Network, Toronto, Ontario;
Dr Shereen Ezzat, Endocrine Oncologist, Mt Sinai Hospital, Toronto, Ontario
Duration: 59 minutes
View:
broadband video
|
standard video
|
audio (MP3)
- Treatment of NETs
Presenter(s): Dr. Thomas O'Dorisio, Endocrinologist, Department of Internal Medicine, University of Iowa
Duration: 39 minutes
View:
broadband video
|
standard video
|
audio (MP3)
- The PROMID Study:
Sandostatin Therapy Trial Demonstrates Tumour Regression is Achievable
Presenter(s): Prof Dr Rudolf Arnold, Department of Internal Medicine, Phillips University, Marburg, Germany
Duration: 33 minutes
View:
broadband video
|
standard video
|
audio (MP3)
- Patients' Insight into Lung Carcinoid Cancer - 3 Case Studies
Presenter(s): Kathy Arbanasin PhD; Joanne Ferguson, RN, BScN
Duration: 21 minutes
View:
broadband video
|
standard video
|
audio (MP3)
-
Surgical Resection of NETS
Presenter(s): Dr Daryl Gray, Surgical Oncologist, London Health Sciences Centre, London, Ontario
Duration: 26 minutes
View:
broadband video
|
standard video
|
audio (MP3)
-
Radionuclide Treatment of NETs - What Patients in the UK Experience
Presenter(s): Dr John Buscombe, Royal Free Hospital, London, UK
Duration: 38 minutes
View:
broadband video
|
standard video
|
audio (MP3)
- Radiopeptides for Diagnosis (receptor PET/CT) and Therapy (PRRT)
Presenter(s): Prof Dr Richard Baum, Zentralklinik, Bad Berka, Germany
Duration: 58 minutes
View:
broadband video
|
standard video
|
audio (MP3)
-
How to Meet the Needs of a Growing Canadian NET Community
Presenter(s): Dr Jean-Luc Urbain, President-Canadian Society of Nuclear Medicine,
Head of Nuclear Medicine-University of Western Ontario
Duration: 36 minutes
View:
broadband video
|
standard video
|
audio (MP3)
-
Audience Question and Answer (followed by official acknowledgements)
Presenter(s): Physicians' Panel and Maureen Coleman, President, CNETS Canada
Duration: 1 hour 4 minutes
View:
broadband video
|
standard video
|
audio (MP3)
|
|
|
 |
|
About CNETS Canada
The Carcinoid-NeuroEndocrine Tumour Society-Canada (CNETS Canada) was formed in 2007 to assist
the Canadian patient and physician community to better understand diagnostic and treatment
options for neuroendocrine cancer patients. Carcinoid cancer patients represent over 50% of
this neuroendocrine cancer spectrum.
|
|
| Event Sponsors |
|
Novartis Oncology
|
|
Ipsen
|
|
Nordion
|
|
Lantheus Medical Imaging
|
|
Draximage
|
|
| Photo Credits |
Event photos © 2009 by
Silvia Steinhilber,
Treasurer CNETS Canada and
Winnipeg Support Group Leader
Additional photography by Ryan Litovitch
|
|
| Donate |
|
| Podcasts |
|
You can download all the conference MP3 audio files for enjoyment on your iPod or mobile phone. Just copy the
link below into iTunes or any similar tool using the 'subscribe to podcast' feature, let the audio
files download to your PC's hard disc and then sync them with your mobile device.
|
Audio Podcast Listing (RSS)
|
|
